The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes

Journal of Dermatological Science

Volumn 22, Issue 1, 1999, Pages 17-23

  Park, Y M ^a   Kim, C W ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cultured human keratinocyte; Interleukin 6; Substance P; Vasoactive intestinal peptide

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; RECOMBINANT GAMMA INTERFERON; SPANTIDE; SUBSTANCE P; SUBSTANCE P ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS;

ANIMALS; CATTLE; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-6; KERATINOCYTES; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032715161     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(99)00038-9     Document Type: Article

References (22)

1. Wong G.G., Clark S.C. Multiple actions of interleukin 6 within cytokine network. Immunol Today. 9:1988;137-141.
2. Neuner P., Urbanski A., Trautinger F., Möller A., Kirnbauer R., Kapp A., Schöpf E., Schwarz T., Luger T.A. Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol. 97:1991;27-33.
3. Kupper T.S., Min K., Sehgal P., Mizutani H., Birchall N., Ray A., May L. Production of IL-6 by keratinocytes: implication of epidermal inflammation and immunity. Ann NY Acad Sci. 557:1989;454-464.
4. Lotti T., Hautmann G., Panconesi E. Neuropeptides in skin. J Am Acad Dermatol. 33:1995;482-496.
5. Nilsson J., von Euler A.M., Dalsgaard C.J. Stimulation of connective tissue cell growth by substance P and substance K. Nature. 315:1985;61-63.
6. Rabier M.J., Farber E.M., Wilkinson D.I. Neuropeptides modulate leukotriene B4 mitogenecity toward cultured human keratinocytes. J Invest Dermatol. 100:1993;132-136.
7. Pincelli C., Fantini F., Romualdi P., Cinzia S., Lesa G., Benassi L., Giannetti A. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured keratinocytes. J Invest Dermatol. 98:1992;421-427.
8. von Restoroff B., Kemeny L., Michel G., Ruzicka T. Specific binding of substance P in normal human keratinocytes. J Invest Dermatol. 98:1992;510. [Abstract].
9. Haegerstrand A., Jonzon B., Dalsgaard C.J., Nilsson J. Vasoactive intestinal peptide stimulates cell proliferation and adenyl cyclase activity of cultured keratinocytes. Proc Natl Acad Sci USA. 86:1989;5993-5996.
10. Lotz M., Vaughan J.H., Carson D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 241:1988;1218-1221.
11. Rameshwar P., Ganea D., Gascon P. Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6. J Immunol. 152:1994;4044-4054.
12. Kavelaars A., Broeke D., Jeurissen F., Kardux J., Meijer A., Franklin R., Gelfand E.W., Heijnen C.J. Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phopholipase D, MAP kinase, and IL-6 production. J Immunol. 153:1994;3691-3699.
13. Lieb K., Fiebich B.L., Busse-Grawitz M., Hüll M., Berger M., Bauer J. Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1β and interleukin-6 in human monocytes: a re-examination. J Neuroimmunol. 67:1996;77-81.
14. Gitter B.D., Regoli D., Howbert J.J., Glasebrook A.L., Waters D.C. Interleukin-6 secretion from human astrocytoma cells induced by substance P. J Neuroimmunol. 51:1994;101-108.
15. Spangelo B.L., Isakson P.C., MaCLeod R.M. Production of interleukin-6 by anterior pituitary cells is stimulated by intercellular adenosine 3′, 5′-monophosphate and vasoactive intestinal peptide. Endocrinology. 127:1990;403-409.
16. Boyce S.T., Ham S.T. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined cultures and serum-free serial culture. J Invest Dermatol. 81:1983;33s-40.
17. Kishimoto T. The biology of interleukin-6. Blood. 74:1989;1-10.
18. Kirnbauer R., Köck A., Schwarz T., Urbanski A., Krutmann J., Borth W., Damm D., Shipley G., Ansel J.C., Luger T.A. IFN-β2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol. 142:1989;1922-1928.
19. Payan D.G., Brewster D.R., Goetzl E.J. Specific stimulation of human T lymphocytes by substance P. J Immunol. 131:1984;1613-1615.
20. Laurenzi M.A., Persson M.A., Dalsgaard C.J., Ringden O. Stimulation of human B lymphocyte differentiation by the neuropeptides substance P and neurokinin A. Scand J Immunol. 30:1989;695-701.
21. Prens E.P., Benne K., van Damme J., Bakkus M., Brakel K., Benner R., van Joost T. Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol. 95:1990;121s-124.
22. Brown J., Perry P., Hefeneider S.H., Ansel J.C. Neuropeptide modulation of keratinocyte cytokine production. Molecular and Cellular Biology of Cytokines. 1990;451-456 Wiley-Liss, New York.